Omeros Corporation
OMER
#6467
Rank
C$1.05 B
Marketcap
C$14.85
Share price
-2.99%
Change (1 day)
-9.66%
Change (1 year)

P/E ratio for Omeros Corporation (OMER)

P/E ratio as of December 2025 (TTM): -5.23

According to Omeros Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -5.22749. At the end of 2024 the company had a P/E ratio of -3.66.

P/E ratio history for Omeros Corporation from 2009 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-3.66
20223.0144.81%
20212.08-134.95%
2020-5.95-28.16%
2019-8.2994.19%
2018-4.27-74.3%
2017-16.6176.22%
2016-6.01-23.56%
2015-7.86-29.54%
2014-11.2
2012-3.26

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Eterna Therapeutics
ERNA
-0.0171-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Pfizer
PFE
14.9-385.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
19.4-471.03%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.